News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • UBS raised its Brent forecast to $100/bbl for end-June 2026, citing sustained Strait of Hormuz shipment restrictions that keep upward price pressure.
  • British equities fell and oil topped $100 as U.S.-Iran talks collapsed and a potential U.S. blockade of the Strait of Hormuz loomed.
  • Revolution Medicines reported Phase 3 pancreatic trial met all primary and key secondary endpoints, sending shares higher and preparing global regulatory filings.
  • Allogene shares rose after interim ALPHA3 data showed substantially higher MRD clearance and marked ctDNA reductions in first-line consolidation patients.
  • JPMorgan told investors to buy pullbacks, arguing market setup supports another rapid V-shaped recovery despite renewed Middle East tensions.
  • Barclays cut its U.S. Q1 GDP growth forecast to a 2.5% annualized pace after weak consumer spending, flagging downside activity risks.

Latest Articles

Horizon Kinetics Reports One-Share Purchase of Texas Pacific Land; TPL Advances Data Center Partnership and Sets Stock Split Dates

Horizon Kinetics Reports One-Share Purchase of Texas Pacific Land; TPL Advances Data Center Partnership and Sets Stock Split Dates

Horizon Kinetics Asset Management LLC, a roughly 10% shareholder in Texas Pacific Land Corp (TPL), reported acquiring a single share of common stock on February 13, 2026, at $426.38, with a reported transaction value of $426. After the trade, Horizon Kinetics directly holds 3,479,373 shares. Separately, TPL announced a strategic partnership with Bo…

SEC Chair Signals Move to Narrow Executive Pay Disclosures

SEC Chair Signals Move to Narrow Executive Pay Disclosures

The chair of the U.S. Securities and Exchange Commission indicated regulators are considering limiting which senior executives must be included in detailed investor disclosures about compensation. The proposals, part of a wider agenda to ease compliance burdens on public companies, could also simplify pay-versus-performance metrics and change repor…

DA Davidson Lifts PDF Solutions Price Target Citing Strong Revenue Momentum

DA Davidson Lifts PDF Solutions Price Target Citing Strong Revenue Momentum

DA Davidson has increased its price target for PDF Solutions Inc. (NASDAQ: PDFS) to $38 from $36 while retaining a Buy recommendation, a move tied to stronger-than-expected fourth-quarter 2025 revenue and an optimistic 2026 revenue outlook. The new target implies roughly 16% upside from the stock's current price of $32.84. The firm’s valuation assu…

Truist Lowers Neurocrine Price Target Citing Larger-Than-Expected Spending

Truist Lowers Neurocrine Price Target Citing Larger-Than-Expected Spending

Truist Securities trimmed its price target on Neurocrine Biosciences to $140 from $169 while retaining a Buy rating after updating its model to reflect higher operating expenses following the company's fourth-quarter 2025 results and 2026 guidance. The adjustment follows management's projection of materially increased spending, particularly in rese…

Truist Lowers Wendy’s Price Target as Turnaround Encounters Headwinds

Truist Lowers Wendy’s Price Target as Turnaround Encounters Headwinds

Truist Securities reduced its price target on Wendy’s Co. (WEN) to $10 from $11 while keeping a Buy rating, citing a weak start to 2026 and intensified competition. The chain reported mixed fourth-quarter 2025 results and modest fiscal 2026 guidance, prompting several analysts to lower forecasts. Despite operational pressures, Wendy’s retains a hig…

DA Davidson Lowers Expedia Price Target Amid Modest 2026 Margin Guidance

DA Davidson Lowers Expedia Price Target Amid Modest 2026 Margin Guidance

DA Davidson trimmed its 12-month price target on Expedia Group Inc. to $260 from $294 while keeping a Neutral rating, following the company's fourth-quarter and full-year 2025 results. Expedia delivered solid top-line performance, substantial margin improvements and robust B2B growth in 2025, but its initial 2026 adjusted EBITDA margin guidance of …

DA Davidson Keeps Buy on Datadog After Investor Day, Signals Confidence in Autonomous Observability Push

DA Davidson Keeps Buy on Datadog After Investor Day, Signals Confidence in Autonomous Observability Push

DA Davidson reaffirmed a Buy rating on Datadog and kept a $225.00 price target after attending the company's investor day in New York City, where management detailed its autonomous observability strategy, AI product roadmap and disclosed ARR metrics for Security customers and AI use cases. The stock trades at $121.04 with a stretched P/E of 396.19,…

Sana Biotechnology Names New CFO as Shares Slip

Sana Biotechnology Names New CFO as Shares Slip

Sana Biotechnology shares declined after the company appointed Brian Piper as Executive Vice President and Chief Financial Officer. Piper brings more than 25 years of biopharma finance experience and will join as the company progresses toward near-term clinical data for SC451 and SG293, programs management says will create key value inflection poin…

ATN International: Approval Risk Clouds Tower Sale, but Balance-Sheet Boost Makes a Mid-Term Long Attractive

ATN International: Approval Risk Clouds Tower Sale, but Balance-Sheet Boost Makes a Mid-Term Long Attractive

ATN announced the sale of a 214-tower U.S. portfolio for up to $297M on 02/11/2026, with expected initial closing in Q2 2026 and $250-270M in gross proceeds. While closing and approvals are not guaranteed and the asset sale reduces revenue and EBITDA, the cash proceeds materially de-lever the business and support a re-rate. We favor a mid-term long…